Porsolt is vigorously continuing our research and collaborations in 2023 with our most recent publication in partnership with COMETE INSERM/UNICAEN UMR-S1075 on ex-vivo hippocampal synaptic plasticity. The research paper entitled…
The airway inflammation model, induced by the administration of bacterial LPS, is a good example of the versatility of Porsolt’s capabilities in determining the anti-inflammatory effects of test substances. Numerous…
Porsolt is attending the European Association for Cancer Research (EACR) meeting this week in Seville, Spain. We are presenting 2 posters describing how preclinical models assist with identifying new therapeutic options…
Porsolt is thrilled to already have our third paper published for this year: “Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T…
Safety Regulatory Package: GLP Pharmacology Adherence to Good Laboratory Practice (GLP) in drug development transcends regulatory requirements; it embodies a profound commitment to safety and quality. As a global contract…